181 related articles for article (PubMed ID: 4092724)
21. Tissue extraction of amiodarone and N-desethylamiodarone in man after a single oral dose.
Berdeaux A; Roche A; Labaille T; Giroux B; Edouard A; Giudicelli JF
Br J Clin Pharmacol; 1984 Nov; 18(5):759-63. PubMed ID: 6508984
[TBL] [Abstract][Full Text] [Related]
22. Plasma and red blood cell concentrations of amiodarone during chronic therapy.
Heger JJ; Solow EB; Prystowsky EN; Zipes DP
Am J Cardiol; 1984 Mar; 53(7):912-7. PubMed ID: 6538381
[TBL] [Abstract][Full Text] [Related]
23. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
[TBL] [Abstract][Full Text] [Related]
24. Renal elimination of amiodarone and its desethyl metabolite.
Harris L; Hind CR; McKenna WJ; Savage C; Krikler SJ; Storey GC; Holt DW
Postgrad Med J; 1983 Jul; 59(693):440-2. PubMed ID: 6622326
[TBL] [Abstract][Full Text] [Related]
25. Value of hepatic computerized tomographic scanning during amiodarone therapy.
Markos J; Veronese ME; Nicholson MR; McLean S; Shevland JE
Am J Cardiol; 1985 Jul; 56(1):89-92. PubMed ID: 4014047
[TBL] [Abstract][Full Text] [Related]
26. Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat.
Safran M; Fang SL; Bambini G; Pinchera A; Martino E; Braverman LE
Am J Med Sci; 1986 Sep; 292(3):136-41. PubMed ID: 3752159
[TBL] [Abstract][Full Text] [Related]
27. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
Adams PC; Holt DW; Storey GC; Morley AR; Callaghan J; Campbell RW
Circulation; 1985 Nov; 72(5):1064-75. PubMed ID: 3930086
[TBL] [Abstract][Full Text] [Related]
28. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
Escoubet B; Jaillon P; Berger Y; Commin P; Menasché P; Piwnica A; Echter E
Am Heart J; 1986 Feb; 111(2):280-5. PubMed ID: 3946169
[TBL] [Abstract][Full Text] [Related]
29. Digoxin-desethylamiodarone interaction in the rat: comparison with the effects of amiodarone.
Venkatesh N; Singh BN; Al-Sarraf L; Kannan R
J Cardiovasc Pharmacol; 1986; 8(2):309-13. PubMed ID: 2422469
[TBL] [Abstract][Full Text] [Related]
30. Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
Riva E; Hearse DJ
Cardiovasc Res; 1989 Apr; 23(4):331-9. PubMed ID: 2590914
[TBL] [Abstract][Full Text] [Related]
31. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
[TBL] [Abstract][Full Text] [Related]
32. Amiodarone and desethylamiodarone tissue uptake in rats chronically treated with amiodarone is non-linear with the dose.
Latini R; Bizzi A; Cini M; Veneroni E; Marchi S; Riva E
J Pharm Pharmacol; 1987 Jun; 39(6):426-31. PubMed ID: 2886599
[TBL] [Abstract][Full Text] [Related]
33. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.
Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F
Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032
[TBL] [Abstract][Full Text] [Related]
34. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
Somani P; Bandyopadhyay S; Klaunig JE; Gross SA
Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095
[TBL] [Abstract][Full Text] [Related]
35. Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation.
Giardina EG; Schneider M; Barr ML
J Am Coll Cardiol; 1990 Oct; 16(4):943-7. PubMed ID: 2212375
[TBL] [Abstract][Full Text] [Related]
36. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Zipes DP; Prystowsky EN; Heger JJ
J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
[TBL] [Abstract][Full Text] [Related]
37. The pathogenesis of amiodarone-induced pigmentation and photosensitivity.
Zachary CB; Slater DN; Holt DW; Storey GC; MacDonald DM
Br J Dermatol; 1984 Apr; 110(4):451-6. PubMed ID: 6712888
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes.
Beddows SA; Page SR; Taylor AH; McNerney R; Whitley GS; Johnstone AP; Nussey SS
Biochem Pharmacol; 1989 Dec; 38(24):4397-403. PubMed ID: 2604742
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture.
Antonini JM; Reasor MJ
Biochem Pharmacol; 1991 Dec; 42 Suppl():S151-6. PubMed ID: 1768272
[TBL] [Abstract][Full Text] [Related]
40. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]